Serotonin receptor agonist 5-nonyloxytryptamine alters the kinetics of reovirus cell entry

Journal of Virology

Volumn 89, Issue 17, 2015, Pages 8701-8712

  Mainou, Bernardo A ^a   Ashbrook, Alison W ^a   Smith, Everett Clinton ^a   Dorset, Daniel C ^a   Denison, Mark R ^a   Dermody, Terence S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 NONYLOXYTRYPTAMINE; JUNCTIONAL ADHESION MOLECULE A; METHIOTHEPIN MESYLATE; SEROTONIN AGONIST; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG; 5-(NONYLOXY)TRYPTAMINE; ANTIVIRUS AGENT; CHOLERA TOXIN; GAMMA INTERFERON; METITEPINE; SEROTONIN ANTAGONIST; TRANSFERRIN; TRYPTAMINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CHIKUNGUNYA VIRUS; CONTROLLED STUDY; CYTOTOXICITY; ENDOSOME; IN VITRO STUDY; MURINE HEPATITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOVIRIDAE; REOVIRUS INFECTION; SIGNAL TRANSDUCTION; TRANSPORT KINETICS; VIRION; VIRUS ASSEMBLY; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTIVITY; ANIMAL; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; CHLOROCEBUS AETHIOPS; CYTOSKELETON; DRUG EFFECTS; HAMSTER; HELA CELL LINE; HUMAN; L CELL LINE; METABOLISM; MOUSE; PATHOGENICITY; PHYSIOLOGY; REOVIRIDAE INFECTIONS; TRANSPORT AT THE CELLULAR LEVEL; VERO CELL LINE; VIROLOGY;

ALPHAVIRUS; CHIKUNGUNYA VIRUS; CORONAVIRUS; MAMMALIA; MAMMALIAN ORTHOREOVIRUSES; MURINE HEPATITIS VIRUS; ORTHOREOVIRUS; RNA VIRUSES;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL TRANSPORT; CELL LINE; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; CHIKUNGUNYA VIRUS; CHOLERA TOXIN; CRICETINAE; CYTOSKELETON; ENDOSOMES; HELA CELLS; HUMANS; INTERFERON-GAMMA; L CELLS (CELL LINE); METHIOTHEPIN; MICE; MURINE HEPATITIS VIRUS; REOVIRIDAE; REOVIRIDAE INFECTIONS; SEROTONIN ANTAGONISTS; TRANSFERRIN; TRYPTAMINES; VERO CELLS; VIRUS ASSEMBLY; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 84938924349     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00739-15     Document Type: Article

References (77)

1. Dermody TS, Parker J, Sherry B. 2013. Orthoreoviruses, p 1304-1346. In Knipe DM, Howley PM (ed), Fields virology, 6th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Ouattara LA, Barin F, Barthez MA, Bonnaud B, Roingeard P, Goudeau A, Castelnau P, Vernet G, Paranhos-Baccala G, Komurian-Pradel F. 2011. Novel human reovirus isolated from children with acute necrotizing encephalopathy. Emerg Infect Dis 17:1436-1444. http://dx.doi.org/10.3201/eid1708.101528.
3. Duncan MR, Stanish SM, Cox DC. 1978. Differential sensitivity of normal and transformed human cells to reovirus infection. J Virol 28: 444-449.
4. Lai CM, Mainou BA, Kim KS, Dermody TS. 2013. Directional release of reovirus from the apical surface of polarized endothelial cells. mBio 4(2): e00049-13. http://dx.doi.org/10.1128/mBio.00049-13.
5. Strong JE, Coffey MC, Tang D, Sabinin P, Lee PW. 1998. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J 17:3351-3362. http://dx.doi.org/10.1093/emboj/17.12.3351.
6. Berger AK, Danthi P. 2013. Reovirus activates a caspase-independent cell death pathway. mBio 4(3):e00178-13. http://dx.doi.org/10.1128/mBio.00178-13.
7. Danthi P, Holm GH, Stehle T, Dermody TS. 2013. Reovirus receptors, cell entry, and proapoptotic signaling. Adv Exp Med Biol 790:42-71. http://dx.doi.org/10.1007/978-1-4614-7651-1_3.
8. Kominsky DJ, Bickel RJ, Tyler KL. 2002. Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. J Virol 76:11414-11424. http://dx.doi.org/10.1128/JVI.76.22.11414-11424.2002.
9. Maitra R, Ghalib MH, Goel S. 2012. Reovirus: a targeted therapeutic-progress and potential. Mol Cancer Res 10:1514-1525. http://dx.doi.org/10.1158/1541-7786.MCR-12-0157.
10. Chakrabarty R, Tran H, Selvaggi G, Hagerman A, Thompson B, Coffey M. 2015. The oncolytic virus, pelareorep, as a novel anticancer agent: a review. Invest New Drugs 33:761-774. http://dx.doi.org/10.1007/s10637-015-0216-8.
11. Barton ES, Connolly JL, Forrest JC, Chappell JD, Dermody TS. 2001. Utilization of sialic acid as a coreceptor enhances reovirus attachment by multistep adhesion strengthening. J Biol Chem 276:2200-2211. http://dx.doi.org/10.1074/jbc.M004680200.
12. Reiss K, Stencel JE, Liu Y, Blaum BS, Reiter DM, Feizi T, Dermody TS, Stehle T. 2012. The GM2 glycan serves as a functional coreceptor for serotype 1 reovirus. PLoS Pathog 8:e1003078. http://dx.doi.org/10.1371/journal.ppat.1003078.
13. Barton ES, Forrest JC, Connolly JL, Chappell JD, Liu Y, Schnell FJ, Nusrat A, Parkos CA, Dermody TS. 2001. Junction adhesion molecule is a receptor for reovirus. Cell 104:441-451. http://dx.doi.org/10.1016/S0092-8674(01)00231-8.
14. Campbell JA, Shelling P, Wetzel JD, Johnson EM, Wilson GAR, Forrest JC, Aurrand-Lions M, Imhof B, Stehle T, Dermody TS. 2005. Junctional adhesion molecule A serves as a receptor for prototype and field-isolate strains of mammalian reovirus. J Virol 79:7967-7978. http://dx.doi.org/10.1128/JVI.79.13.7967-7978.2005.
15. Forrest JC, Campbell JA, Schelling P, Stehle T, Dermody TS. 2003. Structure-function analysis of reovirus binding to junctional adhesion molecule 1. Implications for the mechanism of reovirus attachment. J Biol Chem 278:48434-48444.
16. Konopka-Anstadt JL, Mainou BA, Sutherland DM, Sekine Y, Strittmatter SM, Dermody TS. 2014. The Nogo receptor NgR1 mediates infection by mammalian reovirus. Cell Host Microbe 15:681-691. http://dx.doi.org/10.1016/j.chom.2014.05.010.
17. Maginnis MS, Forrest JC, Kopecky-Bromberg SA, Dickeson SK, Santoro SA, Zutter MM, Nemerow GR, Bergelson JM, Dermody TS. 2006. Beta1 integrin mediates internalization of mammalian reovirus. J Virol 80:2760-2770. http://dx.doi.org/10.1128/JVI.80.6.2760-2770.2006.
18. Mainou BA, Dermody TS. 2011. Src kinase mediates productive endocytic sorting of reovirus during cell entry. J Virol 85:3203-3213. http://dx.doi.org/10.1128/JVI.02056-10.
19. Mainou BA, Dermody TS. 2012. Transport to late endosomes is required for efficient reovirus infection. J Virol 86:8346-8358. http://dx.doi.org/10.1128/JVI.00100-12.
20. Boulant S, Stanifer M, Kural C, Cureton DK, Massol R, Nibert ML, Kirchhausen T. 2013. Similar uptake but different trafficking and escape routes of reovirus virions and infectious subvirion particles imaged in polarized Madin-Darby canine kidney cells. Mol Biol Cell 24:1196-1207. http://dx.doi.org/10.1091/mbc.E12-12-0852.
21. Mainou BA, Zamora PF, Ashbrook AW, Dorset DC, Kim KS, Dermody TS. 2013. Reovirus cell entry requires functional microtubules. mBio 4(4): e00405-13. http://dx.doi.org/10.1128/mBio.00405-13.
22. Baer GS, Dermody TS. 1997. Mutations in reovirus outer-capsid protein sigma3 selected during persistent infections of L cells confer resistance to protease inhibitor E64. J Virol 71:4921-4928.
23. Ebert DH, Deussing J, Peters C, Dermody TS. 2002. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem 277:24609-24617. http://dx.doi.org/10.1074/jbc.M201107200.
24. Sturzenbecker LJ, Nibert ML, Furlong DB, Fields BN. 1987. Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol 61:2351-2361.
25. Maratos-Flier E, Goodman MJ, Murray AH, Kahn CR. 1986. Ammonium inhibits processing and cytotoxicity of reovirus, a nonenveloped virus. J Clin Invest 78:1003-1007. http://dx.doi.org/10.1172/JCI112653.
26. Mattson MP, Guthrie PB, Kater SB. 1988. Intracellular messengers in the generation and degeneration of hippocampal neuroarchitecture. J Neurosci Res 21:447-464. http://dx.doi.org/10.1002/jnr.490210236.
27. Michael D, Martin KC, Seger R, Ning MM, Baston R, Kandel ER. 1998. Repeated pulses of serotonin required for long-term facilitation activate mitogen-activated protein kinase in sensory neurons of Aplysia. Proc Natl Acad Sci U S A 95:1864-1869. http://dx.doi.org/10.1073/pnas.95.4.1864.
28. Hagbom M, Istrate C, Engblom D, Karlsson T, Rodriguez-Diaz J, Buesa J, Taylor JA, Loitto VM, Magnusson KE, Ahlman H, Lundgren O, Svensson L. 2011. Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomiting. PLoS Pathog 7:e1002115. http://dx.doi.org/10.1371/journal.ppat.1002115.
29. Spiller R. 2008. Serotonin and GI clinical disorders. Neuropharmacology 55:1072-1080. http://dx.doi.org/10.1016/j.neuropharm.2008.07.016.
30. Nichols DE, Nichols CD. 2008. Serotonin receptors. Chem Rev 108: 1614-1641. http://dx.doi.org/10.1021/cr078224o.
31. Idzko M, Panther E, Stratz C, Muller T, Bayer H, Zissel G, Durk T, Sorichter S, Di Virgilio F, Geissler M, Fiebich B, Herouy Y, Elsner P, Norgauer J, Ferrari D. 2004. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol 172:6011-6019. http://dx.doi.org/10.4049/jimmunol.172.10.6011.
32. Durk T, Panther E, Muller T, Sorichter S, Ferrari D, Pizzirani C, Di Virgilio F, Myrtek D, Norgauer J, Idzko M. 2005. 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. Int Immunol 17:599-606. http://dx.doi.org/10.1093/intimm/dxh242.
33. Young MR, Matthews JP. 1995. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology 84:148-152.
34. Freire-Garabal M, Nunez MJ, Balboa J, Lopez-Delgado P, Gallego R, Garcia-Caballero T, Fernandez-Roel MD, Brenlla J, Rey-Mendez M. 2003. Serotonin upregulates the activity of phagocytosis through 5-HT1A receptors. Br J Pharmacol 139:457-463. http://dx.doi.org/10.1038/sj.bjp.0705188.
35. Nebigil CG, Etienne N, Messaddeq N, Maroteaux L. 2003. Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B receptor signaling. FASEB J 17:1373-1375.
36. Berger M, Gray JA, Roth BL. 2009. The expanded biology of serotonin. Annu Rev Med 60:355-366. http://dx.doi.org/10.1146/annurev.med.60.042307.110802.
37. Hannon J, Hoyer D. 2008. Molecular biology of 5-HT receptors. Behav Brain Res 195:198-213. http://dx.doi.org/10.1016/j.bbr.2008.03.020.
38. Smith JL, Stein DA, Shum D, Fischer MA, Radu C, Bhinder B, Djaballah H, Nelson JA, Fruh K, Hirsch AJ. 2014. Inhibition of dengue virus replication by a class of small-molecule compounds that antagonize dopamine receptor d4 and downstream mitogen-activated protein kinase signaling. J Virol 88:5533-5542. http://dx.doi.org/10.1128/JVI.00365-14.
39. Bayer H, Muller T, Myrtek D, Sorichter S, Ziegenhagen M, Norgauer J, Zissel G, Idzko M. 2007. Serotoninergic receptors on human airway epithelial cells. Am J Respir Cell Mol Biol 36:85-93. http://dx.doi.org/10.1165/rcmb.2006-0151OC.
40. Willins DL, Deutch AY, Roth BL. 1997. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 27:79-82. http://dx.doi.org/10.1002/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A.
41. Glennon RA, Hong SS, Bondarev M, Law H, Dukat M, Rakhi S, Power P, Fan E, Kinneau D, Kamboj R, Teitler M, Herrick-Davis K, Smith C. 1996. Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors. J Med Chem 39:314-322. http://dx.doi.org/10.1021/jm950498t.
42. Glennon RA, Hong SS, Dukat M, Teitler M, Davis K. 1994. 5-(Nonyloxy) tryptamine: a novel high-affinity 5-HT1D beta serotonin receptor agonist. J Med Chem 37:2828-2830. http://dx.doi.org/10.1021/jm00044a001.
43. Elphick GF, Querbes W, Jordan JA, Gee GV, Eash S, Manley K, Dugan A, Stanifer M, Bhatnagar A, Kroeze WK, Roth BL, Atwood WJ. 2004. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380-1383. http://dx.doi.org/10.1126/science.1103492.
44. Assetta B, Maginnis MS, Gracia Ahufinger I, Haley SA, Gee GV, Nelson CD, O'Hara BA, Allen Ramdial SA, Atwood WJ. 2013. 5-HT2 receptors facilitate JC polyomavirus entry. J Virol 87:13490-13498. http://dx.doi.org/10.1128/JVI.02252-13.
45. Maginnis MS, Nelson CD, Atwood WJ. 31 July 2014. JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection. J Neurovirol. http://dx.doi.org/10.1007/s13365-014-0272-4.
46. Chen W, Madden VJ, Bagnell CR, Jr, Baric RS. 1997. Host-derived intracellular immunization against mouse hepatitis virus infection. Virology 228:318-332. http://dx.doi.org/10.1006/viro.1996.8402.
47. Lin HH, Kao JH, Chen PJ, Chen DS. 1996. Mechanism of vertical transmission of hepatitis G. Lancet 347:1116.
48. Virgin HW, IV, Bassel-Duby R, Fields BN, Tyler KL. 1988. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol 62:4594-4604.
49. Furlong DB, Nibert ML, Fields BN. 1988. Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol 62:246-256.
50. Smith RE, Zweerink HJ, Joklik WK. 1969. Polypeptide components of virions, top component and cores of reovirus type 3. Virology 39:791-810. http://dx.doi.org/10.1016/0042-6822(69)90017-8.
51. Morrison TE, Oko L, Montgomery SA, Whitmore AC, Lotstein AR, Gunn BM, Elmore SA, Heise MT. 2011. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am J Pathol 178:32-40. http://dx.doi.org/10.1016/j.ajpath.2010.11.018.
52. Freeman MC, Graham RL, Lu X, Peek CT, Denison MR. 2014. Coronavirus replicase-reporter fusions provide quantitative analysis of replication and replication complex formation. J Virol 88:5319-5327. http://dx.doi.org/10.1128/JVI.00021-14.
53. Virgin HW, IV, Mann MA, Fields BN, Tyler KL. 1991. Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J Virol 65:6772-6781.
54. Iskarpatyoti JA, Willis JZ, Guan J, Morse EA, Ikizler M, Wetzel JD, Dermody TS, Contractor N. 2012. A rapid, automated approach for quantitation of rotavirus and reovirus infectivity. J Virol Methods 184: 1-7. http://dx.doi.org/10.1016/j.jviromet.2012.03.018.
55. Pappert EJ, Goetz CG, Stebbins GT, Belden M, Carvey PM. 1998. 5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. Eur J Pharmacol 347:51-56. http://dx.doi.org/10.1016/S0014-2999(98)00086-7.
56. Borsa J, Morash BD, Sargent MD, Copps TP, Lievaart PA, Szekely JG. 1979. Two modes of entry of reovirus particles into L cells. J Gen Virol 45:161-170. http://dx.doi.org/10.1099/0022-1317-45-1-161.
57. Doyle JD, Danthi P, Kendall EA, Ooms LS, Wetzel JD, Dermody TS. 2012. Molecular determinants of proteolytic disassembly of the reovirus outer capsid. J Biol Chem 287:8029-8038. http://dx.doi.org/10.1074/jbc.M111.334854.
58. Pang H, Le PU, Nabi IR. 2004. Ganglioside GM1 levels are a determinant of the extent of caveolae/raft-dependent endocytosis of cholera toxin to the Golgi apparatus. J Cell Sci 117:1421-1430. http://dx.doi.org/10.1242/jcs.01009.
59. Torgersen ML, Skretting G, van Deurs B, Sandvig K. 2001. Internalization of cholera toxin by different endocytic mechanisms. J Cell Sci 114: 3737-3747.
60. Pearse BM. 1982. Coated vesicles from human placenta carry ferritin, transferrin, and immunoglobulin G. Proc Natl Acad Sci U S A 79:451-455. http://dx.doi.org/10.1073/pnas.79.2.451.
61. Harding C, Heuser J, Stahl P. 1983. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J Cell Biol 97:329-339. http://dx.doi.org/10.1083/jcb.97.2.329.
62. Maginnis MS, Mainou BA, Derdowski A, Johnson EM, Zent R, Dermody TS. 2008. NPXY motifs in the beta1 integrin cytoplasmic tail are required for functional reovirus entry. J Virol 82:3181-3191. http://dx.doi.org/10.1128/JVI.01612-07.
63. Marin P, Becamel C, Dumuis A, Bockaert J. 2012. 5-HT receptorassociated protein networks: new targets for drug discovery in psychiatric disorders? Curr Drug Targets 13:28-52. http://dx.doi.org/10.2174/138945012798868498.
64. Liu M, Yang Y, Gu C, Yue Y, Wu KK, Wu J, Zhu Y. 2007. Spike protein of SARS-CoV stimulates cyclooxygenase-2 expression via both calciumdependent and calcium-independent protein kinase C pathways. FASEB J 21:1586-1596. http://dx.doi.org/10.1096/fj.06-6589com.
65. Lallemand C, Blanchard B, Palmieri M, Lebon P, May E, Tovey MG. 2007. Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB. Oncogene 26:328-338. http://dx.doi.org/10.1038/sj.onc.1209795.
66. Tung WH, Hsieh HL, Lee IT, Yang CM. 2011. Enterovirus 71 modulates a COX-2/PGE2/cAMP-dependent viral replication in human neuroblastoma cells: role of the c-Src/EGFR/p42/p44 MAPK/CREB signaling pathway. J Cell Biochem 112:559-570. http://dx.doi.org/10.1002/jcb.22946.
67. Hellstrand K, Czerkinsky C, Ricksten A, Jansson B, Asea A, Kylefjord H, Hermodsson S. 1993. Role of serotonin in the regulation of interferongamma production by human natural killer cells. J Interferon Res 13:33-38. http://dx.doi.org/10.1089/jir.1993.13.33.
68. Toth DJ, Toth JT, Gulyas G, Balla A, Balla T, Hunyady L, Varnai P. 2012. Acute depletion of plasma membrane phosphatidylinositol 4,5-bisphosphate impairs specific steps in endocytosis of the G-proteincoupled receptor. J Cell Sci 125:2185-2197. http://dx.doi.org/10.1242/jcs.097279.
69. Berry SA, Shah MC, Khan N, Roth BL. 1996. Rapid agonist-induced internalization of the 5-hydroxytryptamine2A receptor occurs via the endosome pathway in vitro. Mol Pharmacol 50:306-313.
70. Martinez CG, Guinea R, Benavente J, Carrasco L. 1996. The entry of reovirus into L cells is dependent on vacuolar proton-ATPase activity. J Virol 70:576-579.
71. Ashbrook AW, Burrack KS, Silva LA, Montgomery SA, Heise MT, Morrison TE, Dermody TS. 2014. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice. J Virol 88:12180-12192. http://dx.doi.org/10.1128/JVI.01672-14.
72. Silva LA, Khomandiak S, Ashbrook AW, Weller R, Heise MT, Morrison TE, Dermody TS. 2014. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. J Virol 88:2385-2397. http://dx.doi.org/10.1128/JVI.03116-13.
73. Reiter DM, Frierson JM, Halvorson EE, Kobayashi T, Dermody TS, Stehle T. 2011. Crystal structure of reovirus attachment protein sigma1 in complex with sialylated oligosaccharides. PLoS Pathog 7:e1002166. http://dx.doi.org/10.1371/journal.ppat.1002166.
74. Chappell JD, Duong JL, Wright BW, Dermody TS. 2000. Identification of carbohydrate-binding domains in the attachment proteins of type 1 and type 3 reoviruses. J Virol 74:8472-8479. http://dx.doi.org/10.1128/JVI.74.18.8472-8479.2000.
75. Qiu Z, Hingley ST, Simmons G, Yu C, Das Sarma J, Bates P, Weiss SR. 2006. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J Virol 80: 5768-5776. http://dx.doi.org/10.1128/JVI.00442-06.
76. Burkard C, Verheije MH, Wicht O, van Kasteren SI, van Kuppeveld FJ, Haagmans BL, Pelkmans L, Rottier PJ, Bosch BJ, de Haan CA. 2014. Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner. PLoS Pathog 10:e1004502. http://dx.doi.org/10.1371/journal.ppat.1004502.
77. Bernard E, Solignat M, Gay B, Chazal N, Higgs S, Devaux C, Briant L. 2010. Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS One 5:e11479. http://dx.doi.org/10.1371/journal.pone.0011479.